Trade LSTA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Lisata Therapeutics, Inc. (LSTA) is trading at US$1.56, down 8.24% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$13.97M. Over the past 52 weeks, LSTA has traded between US$0.99 and US$5.07. On Syfe you can trade LSTA with $0 commission and add it to your watchlist.
| Previous close | US$1.70 |
|---|---|
| Market cap | US$13.97M |
| 52-week range | US$0.99 – US$5.07 |
| Volume | 225.36K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.
Year: 1999
Sector Update: Healthcare Stocks Higher Late Afternoon
Jul 24, 7:35 PM · MT Newswires
Lisata Therapeutics Shares Fall After Terminating Kuva Labs Deal
Jul 24, 6:59 PM · MT Newswires
--HC Wainwright Downgrades Lisata Therapeutics to Neutral From Buy
May 15, 4:39 PM · MT Newswires
Lisata Therapeutics, Inc. (LSTA) stock is trading at US$1.56, -8.24% from the previous close of US$1.70.
The market cap for Lisata Therapeutics, Inc. (LSTA) stock is approximately US$13.97M.
The 52-week high for Lisata Therapeutics, Inc. (LSTA) stock is US$5.07.
The 52-week low for Lisata Therapeutics, Inc. (LSTA) stock is US$0.99.
Lisata Therapeutics, Inc. (LSTA) does not currently pay a dividend.
Stay on top of LSTA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
